Zymeworks
Zymeworks is a publicly listed (NASDAQ:ZYME) clinical-stage biotechnology company developing novel multifunctional biotherapeutics for difficult-to-treat diseases, with a focus on cancer treatments and a royalty-driven business model.
Open roles
8
+4 in the last 30 days
Posting views
39
in the last 30 days, +25 vs the 30 before. One visitor counts once per posting per day.
Reply rate
Not enough data yet.
Time a posting stays open
21 days
median over 11 postings closed in the last 6 months
Postings added vs. removed
Who they hire
What the company's open postings ask for.